Electrocardiogram Monitoring Cleared for Galaxy Watch Active2 by South Korea’s Ministry of Food and Drug Safety

May 25, 2020

Samsung Electronics announced today that the Electrocardiogram (ECG) function of the Samsung Health Monitor app has been cleared by South Korea’s Ministry of Food and Drug Safety (MFDS). The ECG feature uses advanced sensor technology on the Galaxy Watch Active2,1 and will enable users to measure and analyze their heart rhythm for irregularities indicating Atrial Fibrillation (AFib).2

For more information, please see:
https://news.samsung.com/global/electrocardiogram-monitoring-cleared-for-galaxy-watch-active2-by-south-koreas-ministry-of-food-and-drug-safety